| Recruitment status | Open public recruiting |
| Unique ID issued by UMIN | UMIN000027203 |
| Receipt No. | R000031154 |
| Official scientific title of the study | Efficacy and Safety of Endoscopic Ultrasound Guided Central versus Bilateral Celiac Plexus Neurolysis for Managing Abdominal Pain Associated with Pancreatic Cancer |
| Date of disclosure of the study information | 2019/04/01 |
| Last modified on | 2017/05/01 (Ver. 1) |
| Basic information | ||
| Official scientific title of the study | Efficacy and Safety of Endoscopic Ultrasound Guided Central versus Bilateral Celiac Plexus Neurolysis for Managing Abdominal Pain Associated with Pancreatic Cancer | |
| Title of the study (Brief title) | Endoscopic Ultrasound Guided Central versus Bilateral Celiac Plexus Neurolysis for Managing Abdominal Pain Associated with Pancreatic Cancer | |
| Region |
|
|
| Condition | |||
| Condition | is EUS Guided Safe and effective in managing pancreatic cancer pain and with method is better ( Central VS Bilateral
and what is the best time for intervention early or late salvage therapy ? |
||
| Classification by specialty |
|
||
| Classification by malignancy | Malignancy | ||
| Genomic information | YES | ||
| Objectives | |
| Narrative objectives1 | aim of this study is to compare central endoscopic ultrasound guided
versus bilateral celiac plexus neurolysis using absolute alcohol for pain control with pancreatic cancer |
| Basic objectives2 | Others |
| Basic objectives -Others | the optimal time for intervention early vs late salvage therapy |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | Explanatory |
| Developmental phase | |
| Assessment | |
| Primary outcomes | central endoscopic ultrasound guided
versus bilateral celiac plexus neurolysis using absolute alcohol for pain control with pancreatic cancer which is better ? by assessing pain duration before the procedure, the dose and type of analgesic used, and visual analog scale pain score pre and post-treatment at day 7th , 14th and after two months. |
| Key secondary outcomes | The best Time of intervention early or salvage therapy
Decreased requirement for analgesics |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Single blind -participants are blinded |
| Control | Placebo |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | Institution is considered as adjustment factor in dynamic allocation. |
| Blocking | NO |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | First group
- central Endoscopic Ultrasound guided celiac nerve neurolysis in managing pain in patient with pancreatic cancer |
|
| Interventions/Control_2 | second group
- bilateral Endoscopic Ultrasound guided celiac nerve neurolysis in managing pain in patient with pancreatic cancer |
|
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | - age older than 18 years;
- Severe abdominal or back pain due to confirmed pancreatic cancer (surgical biopsy or EUS-FNA) . - Presence of unrespectable pancreatic cancer (distant metastasis; the invasion of celiac trunk or superior mesentery artery) or intolerability to 3 surgery because of other systemic disorders. - Informed consent. |
|||
| Key exclusion criteria | - Patients whose general condition cannot tolerate an endoscopic
procedure. - Patient refusal of the procedure. - Acute abdominal complaint attributed to other causes. - Coagulopathy that makes the procedure risky. |
|||
| Target sample size | 60 | |||
| Research contact person | |
| Name of lead principal investigator | Hussein Hassan Okasha |
| Organization | Cairo university |
| Division name | faculty of medicine |
| Address | 350 Port Said St. Bab El Khalk, Cairo |
| TEL | 00201001000502 |
| okasha.hussein@gmail.com | |
| Public contact | |
| Name of contact person | admin |
| Organization | faculty of medicine |
| Division name | research affair |
| Address | Kasr Al Ainy St. Cairo, Egypt |
| TEL | 0020223682030 |
| Homepage URL | http://medicine.cu.edu.eg |
| Admin@kasralainy.edu.eg | |
| Sponsor | |
| Institute | cairo univesity , faculty of medicine |
| Institute | |
| Department | |
| Funding Source | |
| Organization | cairo univesity , faculty of medicine |
| Organization | |
| Division | |
| Category of Funding Organization | Outside Japan |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Open public recruiting | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000031154 |